Related Experiment Video
Updated: Jul 29, 2026
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
A J Thompson1, X Montalban, F Barkhof
1Department of Clinical Neurology, Institute of Neurology, London, UK.
Annals of Neurology
|June 14, 2000
Summary
New diagnostic criteria for primary progressive multiple sclerosis (PPMS) require at least one year of clinical progression. These criteria define definite, probable, and possible PPMS based on clinical, CSF, MRI, and evoked potential findings.
Area of Science:
- Neurology
- Neuroimmunology
- Clinical Diagnostics
Background:
- Primary progressive multiple sclerosis (PPMS) presents unique diagnostic challenges due to overlapping symptoms with other progressive neurological disorders.
- Current diagnostic criteria for multiple sclerosis (MS) may not adequately address the specificities of PPMS, leading to diagnostic difficulties.
Purpose of the Study:
- To introduce novel diagnostic criteria for PPMS developed from extensive clinical experience.
- To establish standardized definitions for definite, probable, and possible PPMS to improve diagnostic accuracy.
Main Methods:
- Development of new criteria based on a review of PPMS cases and clinical expertise.
- Inclusion of clinical progression, cerebrospinal fluid (CSF) analysis, magnetic resonance imaging (MRI) of brain and spinal cord, and evoked potentials.
- Categorization into three levels of diagnostic certainty: definite, probable, and possible PPMS.
Main Results:
- Preliminary testing on 156 PPMS patients showed 64% met criteria for definite PPMS, 35% for probable PPMS, and 1% for possible PPMS.
- Definite PPMS diagnosis requires evidence of intrathecal immunoglobulin G synthesis plus specific MRI findings (e.g., nine brain lesions, two spinal cord lesions, or combined brain/spinal cord lesions).
Conclusions:
- The proposed criteria offer a structured approach to diagnosing PPMS.
- Prospective validation in new patient cohorts and postmortem examination is necessary to confirm the utility of these criteria.
Related Concept Videos
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...